Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Immunoprecise Antibodies Ltd
IPA
Healthcare
Biotechnology
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem...
Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:IPA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(22)
•••
wallpaper2
X
View Profile
View Bullboard History
Post by
wallpaper2
on Feb 13, 2023 12:57pm
NAS
Has anyone not had a problem with his stock? What a dog.
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Jan 09, 2023 3:39pm
RE:NAS
Your shares will be on the CAD side of your account. I suggest asking RBC to move them into your USD side. Mine shows price converted to CAD amount but after moving to uS side it shows nasdaq price...
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 15, 2022 8:11am
New Press Release - IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2023
BioStrand Completes Integration of 20 Million Proprietary Structural HYFTs™ used as a navigational layer to parse over the protein predictive platforms AlphaFold-2 and Evolutionary Scale Modeling (ESM)-2 FoldHYFTs are now linked together by more than 25 billion relationships within the Knowledge...
read article.
(22)
•••
wallpaper2
X
View Profile
View Bullboard History
Comment by
wallpaper2
on Dec 14, 2022 11:20am
RE:Big week...start of news releases?
SMMT ...Summit Therapeutics just signed a contract with a Chinese Antibody Research Co that included a $500 million upfront payment and a further $4.5 billion royalty agreement. Summit is presenting
...more
(22)
•••
wallpaper2
X
View Profile
View Bullboard History
Post by
wallpaper2
on Dec 11, 2022 3:08pm
Big week...start of news releases?
AGM Dec 13th. Revenue update Dec 15th. 2023 anticipated rollouts with very large $$$$ attatched. The wait could be over.
(1)
•••
Smayich
X
View Profile
View Bullboard History
Post by
Smayich
on Dec 08, 2022 10:48am
NAS
Has anyone had any issues with there stock not transferring ? I'm still showing my holding on the TSX no price Change no volume. Should they have not transferred to the NAS ? My shares are with
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 08, 2022 8:11am
New Press Release - IPA's Subsidiary BioStrand Completes Integration of 20 Million Proprietary Structural HYFTs(TM) and Accelerates in Silico Drug Discovery Developments
Structural HYFT Technology is used as a navigational layer to parse over the protein predictive platforms AlphaFold-2 and Evolutionary Scale Modeling (ESM)-2 FoldHYFT Technology explores formal and explicit biologically relevant knowledge and connects information about sequence, structure, and...
read article.
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Dec 07, 2022 9:41am
Earnings coming Dec 15
I'm looking for a good growth in Revenue.
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Dec 05, 2022 10:17am
IPA investors of note
From https://www.marketbeat.com/instant-alerts/nasdaq-ipa-a-buy-or-sell-right-now-2022-12/ Most interesting from article "Hedge funds have recently added to or reduced their stakes in the
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 05, 2022 8:09am
New Press Release - IPA to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2023 on December 15, 2022
The Company to host an earnings conference call via webcast IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an advanced biotherapeutic research and technology company, today announced that it will host a conference call to discuss its quarterly results and recent...
read article.
(22)
•••
wallpaper2
X
View Profile
View Bullboard History
Comment by
wallpaper2
on Dec 01, 2022 12:52pm
RE:IPA has a Winner with AI
IPA has the potential to receive Royalties and upfront cash on dozens more drug discoveries. Personalized medicine is the wave of the future and lensAI can make it happen in a fraction of the time and
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Dec 01, 2022 9:46am
IPA has a Winner with AI
IPA's Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies https://www.marketscreener.com/quote
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 30, 2022 8:13am
New Press Release - IPA's Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies
IPA (IMMUNOPRECISE ANTIBODIES LTD.) ( “IPA”) (NASDAQ: IPA), an advanced biotherapeutic research and technology company, today announced that BioStrand BV (“BioStrand”), an AI in silico discovery subsidiary of IPA, has entered into a research collaboration and license agreement (the “Agreement...
read article.
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Nov 25, 2022 9:01am
RE:RE:Nasdaq only, no more Little League.
Won't be trading in TO on Monday. Now on Nas only, good move I believe. Take a look at the tech it is awesome. Not only Polytope but the AI. Revenue growth seems to be a no brainer here and a
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Do you want to stay ahead of the markets? See how DealRoom can help.
Growth Rocket 2025 – Why dynaCERT is in the Spotlight